FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308406959> ?p ?o ?g. }

• W4308406959 abstract "<h3>Background</h3> Tumor infiltrating NK (TINK) cells are present and linked to prognosis in many solid tumors.¹ While these cells may have potent antitumor effector function, they are thought to be dysfunctional in the tumor microenvironment (TME).² Because it is difficult to culture potent TINKs from human tumors, relatively little is known about their interactions with various TME components or their potential for therapeutic applications. Here we report reproducible culture of highly potent TINKs from naturally occurring canine sarcomas for use in modeling the human TME. <h3>Methods</h3> Canine sarcoma tumor specimens were cut into fragments and cultured individually in 24-well plates with medium supplemented with 6000 IU/ml of rhIL-2. Expanded wells were maintained separately and autologous tumors were cultured separately. Expanded TINKs and TILs were characterized by flow cytometry and co-cultured with autologous and allogeneic tumor cells at a E:T ratio of 5:1; cytotoxicity of TILs was monitored by tumor confluence in the Incucyte system. <h3>Results</h3> Ninety-six individual fragments were derived from soft tissue sarcomas (STS) and 120 fragments were derived from osteosarcoma. 88 (92%) of fragments from STS tumors and 23(19%) from Osteosarcoma were expanded sufficiently for additional analysis. While most TINKs and TILs were able to kill autologous tumor and resulted in increased Granzyme B expression, we surprisingly found that the number of TINKs (NKp46+) was positively corelated with tumor killing, with pure cultures of NKp46+ cells resulting in complete and efficient tumor elimination. Furthermore, the percentage of CD5+ T cells was negatively corelated with tumor killing. By flow cytometry, we found that NKp46+ TINKs were CD5(dim) TCRαβ− TCRγδ− CD4− B220- CD1d-, with some NKp46+ subpopulations co-expressing CD3 or CD8. Compared with the less potent TIL cultures composed of mainly CD5+ T cells, NKp46+ TINKs secreted significantly higher T1 cytokines (IFN-γ, TNF-α and GM-CSF) after co-cultured with tumor. Tumor stimulation preferentially activated the secretion of TNF-α over IFN-γ from TINKs, with concentration levels of TNF-α about 20 folds higher than IFN-γ, suggesting impotent role of TNF-α in TINK mediated tumor killing. <h3>Conclusions</h3> Our results demonstrated that functional TINKs can be efficiently expanded from canine sarcoma tumor tissue with little NK cell infiltration seen by immunohistochemistry. Future studies using canine TINKs will explore therapeutic potential for targeting, manipulating, and transferring these cells in human. <h3>Acknowledgements</h3> This work was supported by the Northwestern University – Flow Cytometry Core Facility supported by Cancer Center Support Grant (NCI CA060553), the Analytical bioNano Technology Core supported by the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-2025633). CD1d tetramer was acquired from the NIH Tetramer Facility. <h3>References</h3> Cózar B, Greppi M, Carpentier S, Narni-Mancinelli E, Chiossone L, Vivier E. Tumor-infiltrating natural killer cells. <i>Cancer Discov</i>. 2021;<b>11</b>(1):34–44. Nersesian S, Schwartz SL, Grantham SR, MacLean LK, Lee SN, Pugh-Toole M, Boudreau JE. NK cell infiltration is associated with improved overall survival in solid cancers: a systematic review and meta-analysis. <i>Transl Oncol</i>. 2021;<b>14</b>(1):100930." @default.
• W4308406959 created "2022-11-11" @default.
• W4308406959 creator A5012219010 @default.
• W4308406959 creator A5015243707 @default.
• W4308406959 creator A5019140875 @default.
• W4308406959 creator A5026451121 @default.
• W4308406959 creator A5034727989 @default.
• W4308406959 creator A5046641391 @default.
• W4308406959 creator A5047300034 @default.
• W4308406959 creator A5053711327 @default.
• W4308406959 creator A5077877339 @default.
• W4308406959 date "2022-11-01" @default.
• W4308406959 modified "2023-09-25" @default.
• W4308406959 title "1016 IL-2 expanded tumor infiltrated Natural Killer (TINK) cells from canine sarcomas possess potent anti-tumor cytotoxicity" @default.
• W4308406959 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1016" @default.
• W4308406959 hasPublicationYear "2022" @default.
• W4308406959 type Work @default.
• W4308406959 citedByCount "0" @default.
• W4308406959 crossrefType "proceedings-article" @default.
• W4308406959 hasAuthorship W4308406959A5012219010 @default.
• W4308406959 hasAuthorship W4308406959A5015243707 @default.
• W4308406959 hasAuthorship W4308406959A5019140875 @default.
• W4308406959 hasAuthorship W4308406959A5026451121 @default.
• W4308406959 hasAuthorship W4308406959A5034727989 @default.
• W4308406959 hasAuthorship W4308406959A5046641391 @default.
• W4308406959 hasAuthorship W4308406959A5047300034 @default.
• W4308406959 hasAuthorship W4308406959A5053711327 @default.
• W4308406959 hasAuthorship W4308406959A5077877339 @default.
• W4308406959 hasBestOaLocation W43084069591 @default.
• W4308406959 hasConcept C109316439 @default.
• W4308406959 hasConcept C142724271 @default.
• W4308406959 hasConcept C183193105 @default.
• W4308406959 hasConcept C202751555 @default.
• W4308406959 hasConcept C203014093 @default.
• W4308406959 hasConcept C2776062744 @default.
• W4308406959 hasConcept C2776107976 @default.
• W4308406959 hasConcept C2777760704 @default.
• W4308406959 hasConcept C2778256501 @default.
• W4308406959 hasConcept C2780380082 @default.
• W4308406959 hasConcept C3020616263 @default.
• W4308406959 hasConcept C502942594 @default.
• W4308406959 hasConcept C553184892 @default.
• W4308406959 hasConcept C55493867 @default.
• W4308406959 hasConcept C71924100 @default.
• W4308406959 hasConcept C86803240 @default.
• W4308406959 hasConceptScore W4308406959C109316439 @default.
• W4308406959 hasConceptScore W4308406959C142724271 @default.
• W4308406959 hasConceptScore W4308406959C183193105 @default.
• W4308406959 hasConceptScore W4308406959C202751555 @default.
• W4308406959 hasConceptScore W4308406959C203014093 @default.
• W4308406959 hasConceptScore W4308406959C2776062744 @default.
• W4308406959 hasConceptScore W4308406959C2776107976 @default.
• W4308406959 hasConceptScore W4308406959C2777760704 @default.
• W4308406959 hasConceptScore W4308406959C2778256501 @default.
• W4308406959 hasConceptScore W4308406959C2780380082 @default.
• W4308406959 hasConceptScore W4308406959C3020616263 @default.
• W4308406959 hasConceptScore W4308406959C502942594 @default.
• W4308406959 hasConceptScore W4308406959C553184892 @default.
• W4308406959 hasConceptScore W4308406959C55493867 @default.
• W4308406959 hasConceptScore W4308406959C71924100 @default.
• W4308406959 hasConceptScore W4308406959C86803240 @default.
• W4308406959 hasLocation W43084069591 @default.
• W4308406959 hasOpenAccess W4308406959 @default.
• W4308406959 hasPrimaryLocation W43084069591 @default.
• W4308406959 hasRelatedWork W1999887214 @default.
• W4308406959 hasRelatedWork W2012094115 @default.
• W4308406959 hasRelatedWork W2055608934 @default.
• W4308406959 hasRelatedWork W2056839074 @default.
• W4308406959 hasRelatedWork W2080737551 @default.
• W4308406959 hasRelatedWork W2159125893 @default.
• W4308406959 hasRelatedWork W2205347459 @default.
• W4308406959 hasRelatedWork W4225795182 @default.
• W4308406959 hasRelatedWork W4308406959 @default.
• W4308406959 hasRelatedWork W1604584321 @default.
• W4308406959 isParatext "false" @default.
• W4308406959 isRetracted "false" @default.
• W4308406959 workType "article" @default.